Akero Therapeutics Inc buy Bank of America Co.
Start price
27.05.25
/
50%
€42.17
Target price
27.05.26
€56.17
Performance (%)
11.38%
End price
28.05.26
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 11.38%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Bank of America Co. from $63.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten